Insider Transactions in Q1 2024 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 25
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
2,459
-1.24%
|
$2,459
$1.13 P/Share
|
Feb 25
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
24,157
-0.94%
|
$24,157
$1.13 P/Share
|
Feb 25
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,453
-0.41%
|
$3,453
$1.13 P/Share
|
Feb 25
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,010
-0.59%
|
$5,010
$1.13 P/Share
|
Feb 25
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
3,453
-0.41%
|
$3,453
$1.13 P/Share
|
Feb 24
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
2,209
-1.1%
|
$2,209
$1.13 P/Share
|
Feb 24
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
16,115
-0.62%
|
$16,115
$1.13 P/Share
|
Feb 24
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,474
-0.65%
|
$5,474
$1.13 P/Share
|
Feb 24
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,474
-0.64%
|
$5,474
$1.13 P/Share
|
Feb 24
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-0.52%
|
$4,379
$1.13 P/Share
|
Jan 22
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+43.55%
|
-
|
Jan 22
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
712,500
+45.41%
|
-
|
Jan 22
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
712,500
+45.79%
|
-
|
Jan 22
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
712,500
+45.77%
|
-
|
Jan 22
2024
|
Amy Pooler VP, HEAD OF RESEARCH |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+42.74%
|
-
|